Literature DB >> 16142885

Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy.

Geoffrey R Ambler1, Jeffrey Chaitow, Maureen Rogers, David W McDonald, Robert A Ouvrier.   

Abstract

A 6-year-old boy with improving juvenile dermatomyositis (JDM) developed severe and debilitating calcinosis, unresponsive to diltiazem and probenecid. Alendronate produced dramatic improvement within 1 month and by 12 months calcinosis had virtually resolved. The response was followed by bone mineral content measurements.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16142885

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  13 in total

Review 1.  The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors:  Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

Review 2.  Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).

Authors:  Emily G Farrow; Erik A Imel; Kenneth E White
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-10       Impact factor: 4.098

Review 3.  Systemic sclerosis--challenges for clinical practice.

Authors:  Zsuzsanna H McMahan; Laura K Hummers
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

4.  Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis.

Authors:  Jared Martillotti; Douglas Moote; Lawrence Zemel
Journal:  Pediatr Radiol       Date:  2013-07-10

5.  Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy.

Authors:  Hiroko Mori; Yosuke Okada; Kunihiro Yamaoka; Kazuyoshi Saito; Yoshiya Tanaka
Journal:  J Bone Miner Metab       Date:  2011-06-28       Impact factor: 2.626

Review 6.  Treatment of Calcinosis in Juvenile Dermatomyositis.

Authors:  Ovgu Kul Cinar; Charalampia Papadopoulou; Clarissa A Pilkington
Journal:  Curr Rheumatol Rep       Date:  2021-02-08       Impact factor: 4.592

Review 7.  Juvenile dermatomyositis update.

Authors:  Carol B Lindsley
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.592

8.  Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis.

Authors:  María Pilar Cruz-Domínguez; Grettel García-Collinot; Miguel A Saavedra; Gabriela Medina; Rosa Angélica Carranza-Muleiro; Olga Lidia Vera-Lastra; Luis J Jara
Journal:  Clin Rheumatol       Date:  2016-10-07       Impact factor: 2.980

9.  Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome.

Authors:  Isha Saini; Mani Kalaivani; Sushil Kumar Kabra
Journal:  Rheumatol Int       Date:  2016-03-23       Impact factor: 2.631

10.  Microstructure and mineral composition of dystrophic calcification associated with the idiopathic inflammatory myopathies.

Authors:  Naomi Eidelman; Alan Boyde; Andrew J Bushby; Peter G T Howell; Jirun Sun; Dale E Newbury; Frederick W Miller; Pamela G Robey; Lisa G Rider
Journal:  Arthritis Res Ther       Date:  2009-10-26       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.